Feasibility of a New Silicone Hydrogel Lens

March 28, 2014 updated by: Bausch & Lomb Incorporated

A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Lens

The objective of this study is to determine the product feasibility of the investigational contact lens (Test) when compared to the currently marketed Acuvue Oasys contact lens (Control) and the Air Optix Aqua contact lens (Control) when worn by adapted wearers of soft contact lenses.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Rochester, New York, United States, 14609
        • Bausch & Lomb

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must have clear central corneas and be free of any anterior segment disorders.
  • Participants must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Participants must be myopic and require lens correction from -0.75 D to - 4.75D in each eye.

Exclusion Criteria:

  • Participants who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
  • Participants with any systemic disease affecting ocular health.
  • Participants using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Participants with an active ocular disease or are using any ocular medication.
  • Participants who have had any corneal surgery (eg, refractive surgery).
  • Participants who are allergic to any component in the study care products.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Investigational contact lens
Bausch & Lomb
After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.
ACTIVE_COMPARATOR: Acuvue Oasys Contact Lens
Johnson & Johnson Lens
After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.
ACTIVE_COMPARATOR: Air Optix Aqua
Ciba Vision
After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort Throughout the Day - Test Lens vs. Air Optix Aqua Lens
Time Frame: 7 days
Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.
7 days
Comfort Throughout the Day - Test Lens vs. Acuvue Oasys
Time Frame: 7 days
Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Wettability, Test Lens vs. Acuvue Oasys
Time Frame: 7 days
Lens wettability was assessed at each visit as Grade 4 - 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas > 0.5 mm in size).
7 days
Lens Wettability, Test Lens vs. Air Optix Aqua
Time Frame: 7 days
Lens wettability was assessed at each visit as Grade 4 - 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas > 0.5 mm in size).
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Gerard Carains, MCOptom, PhD, Bausch & Lomb Incorporated

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (ACTUAL)

June 1, 2010

Study Completion (ACTUAL)

June 1, 2010

Study Registration Dates

First Submitted

May 25, 2010

First Submitted That Met QC Criteria

May 25, 2010

First Posted (ESTIMATE)

May 26, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

April 30, 2014

Last Update Submitted That Met QC Criteria

March 28, 2014

Last Verified

March 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 655

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Investigational contact lens

Subscribe